Cargando…
The pharmacogenomic landscape of an Indigenous Australian population
Background: Population genomic studies of individuals of Indigenous ancestry have been extremely limited comprising <0.5% of participants in international genetic databases and genome-wide association studies, contributing to a “genomic gap” that limits their access to personalised medicine. Whil...
Autores principales: | Samarasinghe, Sumudu Rangika, Hoy, Wendy, Jadhao, Sudhir, McMorran, Brendan J., Guchelaar, Henk-Jan, Nagaraj, Shivashankar H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241071/ https://www.ncbi.nlm.nih.gov/pubmed/37284308 http://dx.doi.org/10.3389/fphar.2023.1180640 |
Ejemplares similares
-
The genomic landscape of blood groups in Indigenous Australians in remote communities
por: Jadhao, Sudhir, et al.
Publicado: (2022) -
Analysis of the F2LR3 (PAR4) Single Nucleotide Polymorphism (rs773902) in an Indigenous Australian Population
por: Ningtyas, Dian, et al.
Publicado: (2020) -
New Genetic Loci Associated With Chronic Kidney Disease in an Indigenous Australian Population
por: Thomson, Russell J., et al.
Publicado: (2019) -
The Gene-Drug Duality: Exploring the Pharmacogenomics of Indigenous Populations
por: Nagaraj, Shivashankar H., et al.
Publicado: (2021) -
Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice
por: Tafazoli, Alireza, et al.
Publicado: (2021)